NeuroPace Inc (NPCE): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$0.66

Year ended 2025-12-31

2020-12-31 EPS (Diluted) (USD per share) 2025-12-31

Period ended	EPS (Diluted)	Change YoY	Source filing
2025-12-31	-$0.66	n/m	2026-03-03, From 2025-01-01
2024-12-31	-$0.93	n/m	2026-03-03, From 2024-01-01
2023-12-31	-$1.27	n/m	2025-03-04, From 2023-01-01
2022-12-31	-$1.91	n/m	2024-03-05, From 2022-01-01
2021-12-31	-$2.17	n/m	2023-03-02, From 2021-01-01
2020-12-31	-$117.85	n/a	2022-03-10, From 2020-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EPS (Diluted)	Change YoY
NeuroPace Inc (NPCE)	2025-12-31	-$0.66	n/m
Beta Bionics, Inc. (BBNX)	2025-12-31	-$1.81	n/m
Kestra Medical Technologies, Ltd. (KMTS)	2026-04-30	-$2.43	n/m
Pulmonx Corp (LUNG)	2025-12-31	-$1.33	n/m
Anika Therapeutics, Inc. (ANIK)	2025-12-31	-$0.76	n/m
Orasure Technologies Inc (OSUR)	2025-12-31	-$0.94	n/m
Delcath Systems, Inc. (DCTH)	2025-12-31	$0.07	n/m
Iradimed Corp (IRMD)	2025-12-31	$1.75	+16.7%
TELA Bio, Inc. (TELA)	2025-12-31	-$0.83	n/m

Compare NPCE, BBNX, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗